{"id":920786,"date":"2026-07-18T15:12:27","date_gmt":"2026-07-18T20:12:27","guid":{"rendered":"https:\/\/newsycanuse.com\/index.php\/2026\/07\/18\/cro-price-eyes-0-100-after-cronos-app-beta-teases-10x-leveraged-stock-trading\/"},"modified":"2026-07-18T15:12:27","modified_gmt":"2026-07-18T20:12:27","slug":"cro-price-eyes-0-100-after-cronos-app-beta-teases-10x-leveraged-stock-trading","status":"publish","type":"post","link":"https:\/\/newsycanuse.com\/index.php\/2026\/07\/18\/cro-price-eyes-0-100-after-cronos-app-beta-teases-10x-leveraged-stock-trading\/","title":{"rendered":"CRO Price Eyes $0.100 After Cronos App Beta Teases 10x Leveraged Stock Trading"},"content":{"rendered":"
\n
\n
\n
\"Blue<\/figure>\n<\/div>\n
\n

The CRO price finally caught a spark, but it wasn\u2019t the explosive breakout many traders were hoping for. The move followed Cronos App CEO Ryan Wyatt revealing beta screenshots of the upcoming Cronos App, including an example showing Intel (INTC) stock available with up to 10x leverage. Wyatt confirmed that the beta has started rolling out to users who signed up, with a broader launch planned after feedback from early testers.<\/p>\n

Cronos Beta Fuels Fresh Market Interest<\/h2>\n

The beta announcement<\/a> gave CRO enough momentum to bounce from the lower edge of its long-standing demand zone. Even so, buyers quickly ran into resistance at the 20-week EMA band, where the rally stalled instead of accelerating.<\/p>\n

It\u2019s a familiar story. Exciting product updates often create short-term enthusiasm, but sustained rallies usually need stronger follow-through from buyers. For now, the beta rollout has generated attention, yet price action suggests traders remain cautious while waiting for broader adoption of the platform.<\/p>\n

Technical Resistance Still Controls The Trend<\/h2>\n
\"CRO<\/figure>\n

Despite the positive development, the technical picture hasn\u2019t changed dramatically. CRO continues consolidating near the lower border of its range after failing to push above the 20-week EMA.<\/p>\n

\n

\"Add<\/a><\/p>\n<\/div>\n

If demand strengthens and buyers finally reclaim that moving average, the CRO price could extend its recovery toward the $0.100 level from the current support area around $0.060. That would mark a meaningful shift in momentum after months of weakness.<\/p>\n

Support Zone Faces Another Major Test<\/h2>\n

The downside risk hasn\u2019t disappeared either. Since January 2026, the weekly ascending wedge pattern has already broken down, leaving bears with the broader trend advantage.<\/p>\n

Should the CRO price<\/a> lose the $0.060 support area, the decline could continue toward fresh all-time lows. For now, the beta launch has injected optimism, but whether that excitement translates into sustained buying demand remains the key question over the coming weeks.<\/p>\n<\/div>\n

\n
\n

Was this writing helpful?<\/h3>\n